Keywords: Eisai, Inovelon, Epilepsy, Lennox-Gastaut syndrome, Swissmedic, Switzerland

Swissmedic clears Eisai's Inovelon for rare form of epilepsy

Article | 12 July 2012

Print This

Japanese drug major Eisai’s (TYO: 45230) European subsidiary says that the regulatory agency Swissmedic has approval its Inovelon ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in